167 related articles for article (PubMed ID: 22387295)
1. Interplay of macrophages and T cells in the lung vasculature.
Gerasimovskaya E; Kratzer A; Sidiakova A; Salys J; Zamora M; Taraseviciene-Stewart L
Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(10):L1014-22. PubMed ID: 22387295
[TBL] [Abstract][Full Text] [Related]
2. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
[TBL] [Abstract][Full Text] [Related]
3. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
[TBL] [Abstract][Full Text] [Related]
4. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
5. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.
Pinto RF; Higuchi Mde L; Aiello VD
Cardiovasc Pathol; 2004; 13(5):268-75. PubMed ID: 15358341
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
7. RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling.
Lin Q; Fan C; Skinner JT; Hunter EN; Macdonald AA; Illei PB; Yamaji-Kegan K; Johns RA
J Immunol; 2019 Dec; 203(11):2862-2871. PubMed ID: 31611261
[TBL] [Abstract][Full Text] [Related]
8. Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.
Majka SM; Skokan M; Wheeler L; Harral J; Gladson S; Burnham E; Loyd JE; Stenmark KR; Varella-Garcia M; West J
Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L1028-39. PubMed ID: 18931051
[TBL] [Abstract][Full Text] [Related]
9. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.
Savai R; Pullamsetti SS; Kolbe J; Bieniek E; Voswinckel R; Fink L; Scheed A; Ritter C; Dahal BK; Vater A; Klussmann S; Ghofrani HA; Weissmann N; Klepetko W; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2012 Nov; 186(9):897-908. PubMed ID: 22955318
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
Patel M; Predescu D; Bardita C; Chen J; Jeganathan N; Pritchard M; DiBartolo S; Machado R; Predescu S
Am J Pathol; 2017 Mar; 187(3):528-542. PubMed ID: 28068512
[TBL] [Abstract][Full Text] [Related]
12. Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
Yu YA; Malakhau Y; Yu CA; Phelan SJ; Cumming RI; Kan MJ; Mao L; Rajagopal S; Piantadosi CA; Gunn MD
J Immunol; 2020 Mar; 204(6):1474-1485. PubMed ID: 31996456
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
[TBL] [Abstract][Full Text] [Related]
14. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the immunostimulatory activity of rat pulmonary interstitial dendritic cells by cell-cell interactions and cytokines.
Armstrong LR; Christensen PJ; Paine R; Chen GH; McDonald RA; Lim TK; Toews GB
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):682-91. PubMed ID: 7946397
[TBL] [Abstract][Full Text] [Related]
16. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 overexpression induces pulmonary hypertension.
Steiner MK; Syrkina OL; Kolliputi N; Mark EJ; Hales CA; Waxman AB
Circ Res; 2009 Jan; 104(2):236-44, 28p following 244. PubMed ID: 19074475
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
